Achieving Representative Enrollment
OMNI CRS successfully recruited diverse populations across multiple vaccine and treatment studies, demonstrating a broad spectrum of advertising precision and inclusivity in patient targeting.
The Results
RSV + Shingles Study
Criteria: 70+ years, independent daily living
Results: 450 participants in 10 months
RSV Study
Criteria: 65+ years, male/female
Results: 846 participants in 3 months
Cold Flu Vaccine Study
Criteria: 18–65 years, Asian, Hispanic, American Indian, Alaska Native, Native Hawaiian, or Pacific Islander
Results: 70 participants in 3 months
Anthrax Vaccine Study
Criteria: 50+ years, assisted living with minimal aid
Results: 846 participants in 3 months
The Challenge & OMNI CRS' Approach
The Challenge
Diversity requirements across multiple studies such as RSV, shingles, cold/flu, and anthrax vaccines demanded precision targeting and rapid enrollment.
OMNI CRS' Approach
- Rigorous affiliate partner selection for precise and diverse patient outreach
- Creative approval process ensuring compliance and protocol fit
- Real-time monitoring of 70+ indicators to ensure authenticity and ROI
Why It Worked
By tailoring campaigns to specific age, ethnic, and living criteria, OMNI CRS consistently delivered diverse participants, meeting or exceeding enrollment targets across multiple complex trials.
OMNI Success Story
At OMNI CRS, we prioritize recruiting diverse, engaged participants to meet the specific
demographic and ethnic requirements of your clinical trial. Diversity is essential for
ensuring the accuracy, reliability, and generalizability of research outcomes.